A Window of Opportunity Clinical Trial. This study design permits examination of effects of
an oral agent on cancer patients during the "window" between diagnosis of their cancer and
their definitive cancer surgery. Similar to a phase 0 study, the trial design permits
examination of the biologic effects of an agent; in this study pharmacokinetic properties
will be examined.
Study Intervention Description:
Study participants will take the natural botanical compound ATB during a short window (7 to
28 days). Participants will provide blood samples, and saliva samples during Anti-tumor B
(ATB) administration and a portion of the initial tumor biopsy.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.